Meet the DM drug developers is a program organized by the Myotonic Dystrophy Foundation where each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments for myotonic dystrophy sit down with the Myotonic Dystrophy Foundations community to share their progress and answer their questions. Watch Arthex’s presentation on June 10, 2022, where we explain our updated program for the development of ATX-01.

Ver link

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *